FindTrial
Sign In

Approaches to delirium at the end of life in patients with cancer: a scoping review

Approaches to delirium at the end of life in patients with cancer: a scoping review - Approaches to delirium at the end of life in patients with cancer: a scoping review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000051785
Enrollment
Unknown
Registered
2023-08-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with cancer (more than or equal to 80%) 2. Interventions for delirium at the end of life 3. Both pharmacologic and non-pharmacologic interventions are included in this study. The study design to be considered for inclusion is as follows: 1. If there were at least two randomized controlled trial (RCT)s, inclusion was completed. 2. If there were less than 2 RCTs, we included non-RCTs or observational studies with control groups. 3. If there were no RCTs/non-RCTs/observational studies with control groups, single-arm observational studies were considered for inclusion.

Exclusion criteria

Exclusion criteria: 1. Duplicate publications 2. Conference proceedings 3. Research on sedation

Design outcomes

Primary

MeasureTime frame
Approaches to delirium at the end of life in patients with cancer.—

Countries

Japan

Contacts

Public ContactMari TAKEUCHI

Keio University, School of Medicine Department of Neuropsychiatry

maritakeuchi@keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026